Results 291 to 300 of about 529,540 (301)

Anti-Vascular Endothelial Growth Factor Intravitreal Therapy and Macular Ganglion Cell Layer Thickness in Patients with Neovascular Age-Related Macular Degeneration

Current Eye Research, 2019
Solmaz Abdolrahimzadeh, Magda Gharbiya, Martina Formisano   +2 more
exaly  

Complications of Anti-Vascular Endothelial Growth Factor Drugs

Current Drug Therapy, 2012
openaire   +1 more source

Long-Term Outcomes in Eyes Receiving Fixed-Interval Dosing of Anti–Vascular Endothelial Growth Factor Agents for Wet Age-Related Macular Degeneration

Ophthalmology, 2015
Marc C Peden
exaly  

High Variation of Intravitreal Injection Rates and Medicare Anti–Vascular Endothelial Growth Factor Payments per Injection in the United States

Ophthalmology, 2016
Andrew John Barkmeier, Michael A Mahr
exaly  

Intraocular Anti-Vascular Endothelial Growth Factor Therapy

2014
Naresh Mandava, Carolyn Pan
openaire   +1 more source

Vascular development analysis: a study for tertiary anti-vascular endothelial growth factor therapy after second reactivation of retinopathy of prematurity

Frontiers in Medicine
Yu Xu, Pei-Quan Zhao
exaly  

Anti-Vascular Endothelial Growth Factor-Based Angiostatics

2002
Pär Gerwins, Lena Claesson-Welsh
openaire   +1 more source

Intravitreal Anti-Vascular Endothelial Growth Factor Therapy

Mariana R. Thorell, Philip J. Rosenfeld
openaire   +1 more source

22 anti–vascular endothelial growth factor (anti-VEGF) therapyOptical Coherence Tomography and Anti-Vascular Endothelial Growth Factor Therapy

2015
openaire   +1 more source

Development of Anti-Vascular Endothelial Growth Factor Agents

Maya H. Maloney, Sophie J. Bakri
openaire   +1 more source